Jurnal Oftalmologi Indonesia
ISSN 1693-2587
Vol. 7 / No. 4 / Published : 2010-12
Related with : Scholar Yahoo! Bing
Original Article :
Awareness of subconjunctival bleeding on warfarin therapy patient
Author :
- Diana Haryati Kusumastuti*1
- Dewi Rosalina*2
- Ratna Doemilah*3
- Evelyn Komaratih*4
- Department of Ophthalmology, Faculty of Medicine Airlangga University/Dr. Soetomo General Hospital, Surabaya
Abstract :
A case of subconjunctival bleeding as an initial sign of progressive bleeding caused by warfarin therapy on patient with mitralregurgitation, its clinical signs, multidisciplinary approach and management. A 36 years old male came to eye emergency unit with chief complaints such as subconjunctival bleeding and diplopia. He suffered from mitral regurgitation and took warfarin as oralanticoagulant during the previous month. Ophthalmology examination revealed subconjunctival bleeding and chemosis, eyelid hematoma, and proptosis on the left eye. Retinal hemorrhage (flamed shape) and vascular tortuousity were found on both eyes. Orbital CT-Scan showed retrobulbar hemorrhage on lateral side of the left orbita. Laboratory findings were International Normalized Ratio (INR) 5.36, Prothrombin Time >2.01, Activated Partial Thromboplastin Time (APTT) 124. The signs of progressive bleeding of the eye were documented. The patient was consulted to cardiology, pulmonology, and internal department. The advice given was the discontinuation of warfarin and continued with ambulatory treatment. We were aware of the progressive bleeding, and decided to hospitalize the patient. Warfarin was discontinued and vitamin K was administered intravenously. His general condition decreased, and the patient was taken to resuscitation room. Subconjunctival bleeding was the initial sign of progressive multiorgan hemorrhage causing the death of the patient 22 hours later. Massive multiorgan hemorrhage could be caused by warfarin, and subconjunctivalbleeding could be an initial sign of progressive bleeding. It is important to be aware of this sign and detailed history shouldbe taken to find underlying disease. Multidisciplinary management should be undertaken by departments such as cardiology, pulmonology, internal, and anesthesiology.
Keyword :
warfarin, subconjunctival bleeding, multi organ hemorrhage,
References :
-,(2009) Toxicity, Warfarin and Superwarfarins. eMedicine, Emergengcy Medicine - : http://emedicine.medscape.com
Kneeland PP, Fang MC,(2010) Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism - : Patient Prefer Adherence Journal
Rosmiati H, Gan Vincent HS,(1995) Antikoagulan, Antitrombosit. Trombolitik dan Hemostatik; Farmakologi dan Terapi Edisi 4 - : Farmakologi Fakultas Kedokteran Universitas Indonesia
Kerrison JB, Iwamoto A, Merbs SL, Hiff NT,(1998) Orbital Trauma in: Management Of Ocular Injuries And Emergencies Philladelphia : Lippincot – Raven
Superstein R, Gomolin JE, HammoudaW, Rosenberg A, Overbury O, Arsenault C,(2000) Prevalence of Ocular Hemorrhage in Patients Receiving Warfarin Therapy - : Can J Ophthalmol
Archive Article
Cover Media | Content |
---|---|
![]() Volume : 7 / No. : 4 / Pub. : 2010-12 |
|